Directorate Change

RNS Number : 5760V
Asia Dragon Trust PLC
14 December 2021
 

ASIA DRAGON TRUST PLC ('DRAGON')

Legal Entity Identifier (LEI):  549300W4KB0D75D1N730

 

14 December 2021

Director changes - Board Appointment

 

The Board of Asia Dragon Trust plc is pleased to announce the appointment of Matthew Dobbs as an independent non-executive Director of the Company with effect from 1 February 2022.  Matthew will also be appointed as a member of the Audit & Risk, Management Engagement, Nomination and Remuneration Committees.

Matthew spent his 40 year fund management career at Schroders, recently stepping down from full time investment responsibilities.  He is a renowned Asian and Small Companies investment expert having been Schroders' Head of Global Small Companies since 2000.   In addition to managing the Schroders Asian Alpha Plus Fund, Matthew was instrumental in helping grow the assets of two investment trusts, Schroder AsiaPacific Fund plc and Schroder Oriental Income Fund Limited, since their launches in 1995 and 2005, into FTSE 250 Companies.  He holds a BA in history and economics from Oxford University.

Matthew is a non-executive director of the European Opportunities Trust PLC.  H e currently has a beneficial interest in 14,000 shares of the Company.

There are no other disclosures required under Section 9.6.13 (2) to (6) of the Financial Conduct Authority Listing Rules.

 

For Asia Dragon Trust plc

Aberdeen Asset Managers Limited, SECRETARY

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAVZLBFFLLXFBK
UK 100